drugset / Trial / NCT01280188

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

NCT01280188

Phase 3 Completed 20 enrolled Ferring Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label dose-titration study in Japanese Central Diabetes Insipidus (CDI) patients designed to demonstrate the efficacy and safety of orally-disintegrating tablet of desmopressin.

Timeline

Start
2011-01
Primary completion
2011-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 60 ug Oral